Eterna Therapeutics Inc. Board of Directors

Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Mr. Sanjeev Luther

CEO, President & Director

Ms. Sandra M. Gurrola

Principal Financial & Accounting Officer and Senior VP of Finance

Dr. Robert Hamilton Pierce M.D.

Chief Scientific Officer

Ms. Dorothy J. Clarke

General Counsel & Director

Comments

We use cookies

This website uses cookies in order to enhance the overall user experience.

Customize

Essential cookies

There are some cookies that we have to include in order for certain web pages to function. For this reason, they do not require your consent.

board_of_directors_review_cookie_consent

1 year 1 month 1 day

Used to store the user's cookie consent preferences.
board_of_directors_review_session

2 hours

Used to identify the user's browsing session.
XSRF-TOKEN

2 hours

Used to secure both the user and our website against cross-site request forgery attacks.

More details